The 52nd Annual Society of Hematology (ASH) Annual Meeting was held December 4th through 7th, 2010, in Orlando, FL. This report summarizes presentations at the 2010 ASH Annual Meeting, organized by topics rather than by sessions, providing an overview of information on new drugs in development; clinical trial results; treatment by patient characteristics, e.g., transplant eligibility or stage of disease; risk stratification and staging; disease biology including bone disease and use of bisphosphonates; and maintenance therapy. Although maintenance therapy is summarized in its own section, some trials that include maintenance therapy are summarized in more appropriate sections, as many trials are now including some kind of continuing treatment for at
least some patients.
Click on the PDF tab above to read and/or download the document.